Orchard Therapeutics (Sweden) AB
Developing life-transforming HSC gene therapies for severe genetic diseases.
Overview
- 1–4
- Employees
- 5–10M SEK
- Revenue
- 2022
- Founded
Description
Orchard Therapeutics plc is a global biotechnology company dedicated to developing and commercializing potentially life-transforming gene therapies. The organization focuses specifically on hematopoietic stem cell (HSC) gene therapy platforms aimed at treating severe and rare genetic diseases. Their...